Skip to main content
. 2026 Feb 24;26:203. doi: 10.1186/s12871-025-03586-x

Table 3.

Secondary outcomes

FNB QLB p
Intervention time (h) 2.1 ± 0.4 2 ± 0.4 0.43
Time in PACU (h) 2.7 ± 1.1 2.7 ± 1 0.71
VAS at rest
H1 0.7 ± 1.3 1.3 ± 1.8 0.20
H2 0.6 ± 1.4 0.9 ± 1.7 0.22
H6 2.3 ± 2.5 2.4 ± 2.6 0.98
H12 2.2 ± 2.7 2.1 ± 2.4 0.37
H24 2.7 ± 2.3 1.7 ± 2 0.44
VAS on mobilization
H1 2.5 ± 2.2 2.0 ± 2 0.65
H2 1.4 ± 1.6 1.6 ± 1.5 0.69
H6 2.4 ± 2 2.2 ± 2.1 0.85
H12 2.2 ± 2.5 2.4 ± 2.6 0.92
H24 2 ± 2 1.9 ± 1.8 0.48
Paracetamol use (No. of patients) 50 51 0.68
Ketoprofen use (No. of patients) 32 33 0.79
Nefopam use (No. of patients) 12 18 0.19

PACU Post-anesthesia care unit, VAS Visual Analogue Scale, FNB Femoral nerve block, QLB Quadratus lumborum block